Safety and outcome of chemoradiotherapy in elderly patients with rectal cancer: Results from two French tertiary centres

Digestive and Liver Disease

Volumn 44, Issue 4, 2012, Pages 350-354

  Tougeron, David ^a,b,c   Roullet, Bernard ^a   Paillot, Bernard ^b   Hamidou, Hadji ^d   Tourani, Jean Marc ^a   Bensadoun, Réné Jean ^a   Michel, Pierre ^b   Silvain, Christine ^a,c  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE POITIERS   (France)

^d CRLCC Becquerel   (France)

Author keywords

Chemoradiotherapy; Elderly patients; Rectal cancer

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; TEGAFUR;

ADVERSE OUTCOME; AGE DISTRIBUTION; AGED; AGING; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER GRADING; CANCER STAGING; CHEMORADIOTHERAPY; CONTROLLED STUDY; DRUG TOLERABILITY; FEMALE; FISTULA; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIMODALITY CANCER THERAPY; PATIENT SAFETY; PERINEUM ABSCESS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION DOSE; RECTUM CANCER; RETROSPECTIVE STUDY; SEPSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; URINE RETENTION;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHEMORADIOTHERAPY, ADJUVANT; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FRANCE; HUMANS; KAPLAN-MEIER ESTIMATE; LEUCOVORIN; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; TEGAFUR; VITAMIN B COMPLEX;

EID: 84857649723     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.10.017     Document Type: Article

References (37)

1. Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents, vol. VIII. Lyon: International Agency for Research on Cancer; 2002 [IARC Scient. Publ. No. 155].
2. Ferlay J., Autier P., Boniol M., et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007, 18:581-592.
3. Berrino F., De A.R., Sant M., et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-1999: results of the EUROCARE-4 study. Lancet Oncol 2007, 8:773-783.
4. Martijn H., Vulto J.C.M. Should radiotherapy be avoided or delivered differently in elderly patients with rectal cancer?. Eur J Cancer 2007, 43:2301-2306.
5. Kapiteijn E., Marijnen C.A.M., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001, 345:638-646.
6. Bosset J.F., Collette L., Calais G., et al. EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006, 355:1114-1123.
7. Gérard J.P., Conroy T., Bonnetain F., et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006, 24:4620-4625.
8. Ceelen W., Fierens K., Van Nieuwenhove Y., et al. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer: a systematic review and meta-analysis. Int J Cancer 2009, 124:2966-2972.
9. Rödel C., Liersch T., Hermann R.M., et al. Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. J Clin Oncol 2007, 25:110-117.
10. Aschele C., Friso M.L., Pucciarelli S., et al. A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. Ann Oncol 2005, 16:1140-1146.
11. Aschele C, Pinto C, Cordio S, et al. Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: Pathologic response analysis of the Studio Terapia Adiuvante Retto (STAR)-01 randomized phase III trial. 2009 ASCO Annual Meeting. J Clin Oncol 2009;18 (Suppl.) [abstr CRA4008].
12. O'Connell M.J., Martenson J.A., Wieand H.S., et al. Improving adjuvant therapy of rectal cancer by combining protracted infusional fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994, 331:502-507.
13. Zampino M.G., Labianca R., Beretta G.D., et al. Rectal cancer. Crit Rev Oncol Hematol 2009, 70:160-182.
14. Tougeron D., Di Fiore F., Lefebure B., et al. Control of pelvic symptoms in patients with rectal cancer and synchronous metastases. Gastroenterol Clin Biol 2009, 33:1106-1113.
15. Pignon T., Horiot J.C., Bolla M., et al. Age is not a limiting factor for radical radiotherapy in pelvic malignancies. Radiother Oncol 1997, 42:107-120.
16. Pasetto L.M., Basso U., Friso M.L., et al. Determining therapeutic approaches in the elderly with rectal cancer. Drugs Aging 2007, 24:781-790.
17. Lorchel F., Peignaux K., Crehange G., et al. Preoperative radiotherapy in elderly patients with rectal cancer. Gastroenterol Clin Biol 2007, 31:436-441.
18. Fiorica F., Cartei F., Carau B., et al. Adjuvant radiotherapy on older and oldest elderly rectal cancer patients. Arch Gerontol Geriatr 2009, 49:54-59.
19. Carreca I., Balducci L., Extermann M. Cancer in the older person. Cancer Treat Rev 2005, 31:380-402.
20. Pasetto L.M., Friso M.L., Pucciarelli S., et al. Rectal cancer neoadjuvant treatment in elderly patients. Anticancer Res 2006, 26:3913-3923.
21. Fora A, Yang G, BullardDunn K, et al. Chemoradiation in elderly patients with rectal cancer. Gastrointestinal Cancers Symposium; 2009 [General Poster Session E, n° 434].
22. Papamichael D., Audisio R., Horiot J.C., et al. Treatment of the elderly colorectal cancer patient: SIOG expert recommendations. Ann Oncol 2009, 20:5-16.
23. Charlson M.E., Sax F.L., MacKenzie C.R., et al. Morbidity during hospitalization: can we predict it?. J Chron Dis 1987, 40:373-383.
24. Newschaffer C.J., Bush T.I., Penberthy L.T. Comorbidity measurement in elderly female breast cancer patients with administrative medical records data. J Clin Epidemiol 1997, 50:725-733.
25. Reid B.C., Alberg A.J., Klassen A.C., et al. Comorbidity and survival of elderly head and neck carcinoma patients. Cancer 2001, 92:2109-2116.
26. Lichtman S.M. Management of advanced colorectal cancer in older patients. Oncology (Williston Park) 2005, 19:597-602.
27. Guyot F., Faivre J., Manfredi S., et al. Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol 2005, 16:756-761.
28. Esnaola N.F., Cantor S.B., Johnson M.L., et al. Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol 2002, 20:4361-4367.
29. Braendengen M., Tveit K.M., Berglund A., et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 2008, 26:3687-3694.
30. Sebag-Montefiore D., Glynne-Jones R., Falk S., et al. A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study. Br J Cancer 2005, 93:993-998.
31. Rutten H., den Dulk M., Lemmens V., et al. Survival of elderly rectal cancer patients not improved: analysis of population based data on the impact of TME surgery. Eur J Cancer 2007, 43:2295-2300.
32. Shahir M.A., Lemmens V.E., van de Poll-Franse L.V., et al. Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study. Eur J Cancer 2006, 42:3015-3021.
33. Lemmens V.E., Janssen-Heijnen M.L., Houterman S., et al. Which comorbid conditions predict complications after surgery for colorectal cancer?. World J Surg 2007, 31:192-199.
34. Surgery for colorectal cancer in elderly patients: a systematic review. Lancet 2000, 356:968-974. Colorectal Cancer Collaborative Group.
35. Kiran R.P., Pokala N., Dudrick S.J. Long-term outcome after operative intervention for rectal cancer in patients aged over 80 years: analysis of 9,501 patients. Dis Colon Rectum 2007, 50:604-610.
36. Law W.L., Poon J.T., Fan J.K., Lo S.H. Comparison of outcome of open and laparoscopic resection for stage II and stage III rectal cancer. Ann Surg Oncol 2009, 16:1488-1493.
37. Sauer R., Becker H., Hohenberger W., et al. German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004, 351:1731-1740.